Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sjoerd Bruin

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
BMC Gastroenterology|December 22, 2017
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)Thomas C C Boerlage, Sylke Haal, L Maurits de Brauw, et al.
Nature Medicine|October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver diseaseAbraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
The Lancet. Gastroenterology & Hepatology|October 29, 2021
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trialSylke Haal, Maimoena S S Guman, Thomas C C Boerlage, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
BMC Gastroenterology|December 22, 2017
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)Thomas C C Boerlage, Sylke Haal, L Maurits de Brauw, et al.
Nature Medicine|October 10, 2022
Microbiome-derived ethanol in nonalcoholic fatty liver diseaseAbraham S Meijnikman, Mark Davids, Hilde Herrema, et al.
The Lancet. Gastroenterology & Hepatology|October 29, 2021
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trialSylke Haal, Maimoena S S Guman, Thomas C C Boerlage, et al.
Pageof 2